Insider holders · CIK 0000879169
INCYTE CORP · INCY
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| 14159, L.P.Director | 61,049 | 810,862 | 871,911 | Feb 27, 2019 · 5:19 pm EST | Form 4 |
| Baker Bros. Advisors (GP) LLCDirector | 281,190 | 33,410 | 314,600 | Jul 2, 2026 · 4:31 pm EDT | Form 4 |
| 667, L.P.Director | 281,190 | 33,410 | 314,600 | Jul 2, 2026 · 4:31 pm EDT | Form 4 |
| Baker Brothers Life Sciences LPDirector | 281,190 | 33,410 | 314,600 | Jul 2, 2026 · 4:31 pm EDT | Form 4 |
| BAKER BROS. ADVISORS LPDirector | 281,190 | 33,410 | 314,600 | Jul 2, 2026 · 4:31 pm EDT | Form 4 |
| Felix BakerDirector | 281,190 | 33,410 | 314,600 | Jul 2, 2026 · 4:31 pm EDT | Form 4 |
| Julian BakerDirector | 281,190 | 33,410 | 314,600 | Jul 2, 2026 · 4:31 pm EDT | Form 4 |
| Paul A FriedmanDirector | 269,011 | — | 269,011 | Nov 20, 2017 · 4:25 pm EST | Form 4 |
| Herve HoppenotChairman / CEO | 158,503 | 103,033 | 261,536 | Feb 19, 2019 · 7:11 pm EST | Form 4 |
| Paul A BrookeDirector | 198,929 | 40,000 | 238,929 | Jan 3, 2019 · 4:05 pm EST | Form 4 |
| Pablo J CagnoniPresident, Global Head of R&D | 183,200 | — | 183,200 | Sep 17, 2026 · 4:04 pm EDT | Form 4 |
| William MeuryChief Executive Officer | 183,129 | — | 183,129 | Jul 20, 2026 · 4:07 pm EDT | Form 4 |
| Richard U De SchutterDirector | 92,290 | — | 92,290 | Mar 9, 2015 · 4:35 pm EDT | Form 4 |
| Mohamed Khairie IssaEVP, Head of U.S. Commercial | 71,797 | — | 71,797 | Jul 20, 2026 · 4:09 pm EDT | Form 4 |
| Patrick A MayesEVP & Chief Scientific Officer | 61,441 | — | 61,441 | Aug 7, 2026 · 4:01 pm EDT | Form 4 |
| Barry A ArikoDirector | 45,834 | — | 45,834 | Mar 13, 2015 · 4:28 pm EDT | Form 4 |
| Yao WenqingEVP, Head of Discovery Chem | 39,798 | — | 39,798 | Feb 19, 2019 · 6:52 pm EST | Form 4 |
| Paula J SwainEVP, Human Resources | 36,513 | — | 36,513 | Mar 5, 2019 · 4:45 pm EST | Form 4 |
| Reid M HuberEVP, Chief Scientific Officer | 34,571 | — | 34,571 | Jul 18, 2018 · 4:28 pm EDT | Form 4 |
| Steven H SteinCMO & Head of Late-Stage Dev. | 30,916 | — | 30,916 | Jul 20, 2026 · 4:10 pm EDT | Form 4 |
| Paul J ClancyDirector | 25,635 | — | 25,635 | Jul 2, 2026 · 4:08 pm EDT | Form 4 |
| Jean Jacques BienaimeDirector | 24,424 | — | 24,424 | Jun 10, 2026 · 4:06 pm EDT | Form 4 |
| Edmund HarriganDirector | 23,019 | — | 23,019 | Jul 2, 2026 · 4:07 pm EDT | Form 4 |
| Thomas TrayPrincipal Accounting Officer | 21,699 | — | 21,699 | Jul 20, 2026 · 4:10 pm EDT | Form 4 |
| Eric H. SiegelEVP, General Counsel | 21,053 | — | 21,053 | Sep 15, 2017 · 4:28 pm EDT | Form 4 |
| Jacqualyn A FouseDirector | 20,968 | — | 20,968 | Jun 10, 2026 · 4:07 pm EDT | Form 4 |
| Richard S LevyEVP, Chief Drug Dev Officer | 16,926 | — | 16,926 | Jan 8, 2016 · 4:37 pm EST | Form 4 |
| Richard A. HoffmanEVP & General Counsel | 16,861 | — | 16,861 | Jul 20, 2026 · 4:08 pm EDT | Form 4 |
| David H GardnerEVP, Chief Strategy Officer | 15,904 | — | 15,904 | Sep 24, 2026 · 4:06 pm EDT | Form 4 |
| Katherine A HighDirector | 14,983 | — | 14,983 | Jun 10, 2026 · 4:05 pm EDT | Form 4 |
| Barry P FlannellyEVP & General Manager US | 14,333 | — | 14,333 | Feb 19, 2019 · 5:10 pm EST | Form 4 |
| Paul TrowerPrincipal Accounting Officer | 13,900 | — | 13,900 | Jan 17, 2019 · 4:15 pm EST | Form 4 |
| Vijay K IyengarEVP GPS, BD, & Licensing | 13,492 | — | 13,492 | Feb 19, 2019 · 5:21 pm EST | Form 4 |
| Otis W BrawleyDirector | 12,894 | — | 12,894 | Jun 10, 2026 · 4:05 pm EDT | Form 4 |
| Maria E PasqualeEVP & General Counsel | 11,530 | — | 11,530 | Feb 19, 2019 · 5:30 pm EST | Form 4 |
| Ramitpal K BasiEVP, Human Resources | 10,993 | — | 10,993 | Aug 27, 2026 · 4:07 pm EDT | Form 4 |
| Christiana StamoulisEVP & Chief Financial Officer | 10,285 | — | 10,285 | Feb 13, 2019 · 4:20 pm EST | Form 4 |
| David W GryskaExecutive Vice President, CFO | 10,235 | — | 10,235 | Jul 18, 2018 · 4:12 pm EDT | Form 4 |
| Wendy L DixonDirector | 10,199 | — | 10,199 | Jan 3, 2019 · 4:08 pm EST | Form 4 |
| Dashyant DhanakEVP & Chief Scientific Officer | 6,878 | — | 6,878 | Dec 12, 2018 · 4:10 pm EST | Form 4 |
| James M DalyEVP, Chief Commercial Officer | 3,521 | — | 3,521 | Jun 25, 2015 · 4:28 pm EDT | Form 4 |
| Laurent Chardonnetrelationship not stated | 2,905 | — | 2,905 | Apr 1, 2015 · 4:27 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.